Cargando…
Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents
BACKGROUND: High dose estrogens (HDEs) were frequently used as endocrine agents prior to the introduction of tamoxifen which carries fewer side effects. Due to the development of resistance to available endocrine agents in almost all women with metastatic breast cancer, interest has renewed in the u...
Autores principales: | Agrawal, Amit, Robertson, John FR, Cheung, KL |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533829/ https://www.ncbi.nlm.nih.gov/pubmed/16834778 http://dx.doi.org/10.1186/1477-7819-4-44 |
Ejemplares similares
-
"Resurrection of clinical efficacy" after resistance to endocrine therapy in metastatic breast cancer
por: Agrawal, Amit, et al.
Publicado: (2006) -
ENDOCRINE RESPONSE TO AN ULTRA-MARATHON IN PRE- AND POST-MENOPAUSAL WOMEN
por: Copeland, J.L., et al.
Publicado: (2014) -
Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study
por: Iwase, H, et al.
Publicado: (2013) -
Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer
por: Agrawal, Amit, et al.
Publicado: (2011) -
Polyamide-Laccase Nanofiber Membrane for Degradation of Endocrine-Disrupting Bisphenol A, 17α-ethinylestradiol, and Triclosan
por: Maryskova, Milena, et al.
Publicado: (2019)